A Study to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine in Children
Clinical trial NCT01218308 · COMPLETED
Trial details
- NCT number
- NCT01218308
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-12-09
- Primary completion
- 2012-01-09
- Enrollment
- 5220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.